Iain Macleod
Principal investigator, leads ALDATU BIOSCIENCES INC.
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$8.5MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $8.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 19, 2022 | NIH | SBIR Phase II Commercialization of PANDAA qDx for rapid drug resistance genotyping of protease inhibitor ART failures in resource-limited settings. | $2.0M | ALDATU BIOSCIENCES INC |
| Aug 1, 2022 | NIH | SBIR Phase II PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response. | $1.9M | ALDATU BIOSCIENCES INC |
| Mar 24, 2021 | NIH | SBIR Phase II PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus | $1.7M | ALDATU BIOSCIENCES INC |
| Jan 17, 2017 | NIH | SBIR Phase II PANDAA for rapid genotyping of HIV-1 infected patients failing protease inhibitor ART in resource-limited settings | $2.9M | ALDATU BIOSCIENCES INC |
Peer ranks
Federal funding#103
Awards as PI#643
Patents#505
Companies
- ALDATU BIOSCIENCES INCLeads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.